EP3269394 - MACROMOLECULAR DELIVERY SYSTEMS FOR NON-INVASIVE IMAGING, EVALUATION AND TREATMENT OF ARTHRITIS AND OTHER INFLAMMATORY DISEASES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 19.11.2021 Database last updated on 22.01.2025 | |
Former | Grant of patent is intended Status updated on 28.02.2021 | ||
Former | Examination is in progress Status updated on 19.10.2019 | ||
Former | Request for examination was made Status updated on 15.12.2017 | Most recent event Tooltip | 19.11.2021 | Application deemed to be withdrawn | published on 22.12.2021 [2021/51] | Applicant(s) | For all designated states University of Utah Research Foundation 615 Arapeen Drive, Suite 310 Salt Lake City, UT 84108 / US | [2018/03] | Inventor(s) | 01 /
Wang, Dong 12769 Whisper Wind PL Draper, UT 84020 / US | 02 /
Kopocek, Jindrich 1103 Alton Way Salt Lake City, UT 84106 / US | 03 /
Miller, Scott C. 2693 Glenmare Street Salt Lake City, UT 84106 / US | 04 /
Kopecková, Pavla 1103 South Alton Way Salt Lake City, UT 84108 / US | [N/P] |
Former [2018/03] | 01 /
Wang, Dong 12769 Whisper Wind PL Draper, UT Utah 84020 / US | ||
02 /
Kopocek, Jindrich 1103 Alton Way Salt Lake City, UT Utah 84106 / US | |||
03 /
Miller, Scott C. 2693 Glenmare Street Salt Lake City, UT Utah 84106 / US | |||
04 /
Kopecková, Pavla 1103 South Alton Way Salt Lake City, UT Utah 84108 / US | Representative(s) | V.O. P.O. Box 87930 Carnegieplein 5 2508 DH Den Haag / NL | [2018/03] | Application number, filing date | 17188335.8 | 30.03.2005 | [2018/03] | Priority number, date | US20040558047P | 31.03.2004 Original published format: US 558047 P | [2018/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3269394 | Date: | 17.01.2018 | Language: | EN | [2018/03] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 24.11.2017 | Classification | IPC: | A61K47/58, A61K49/00, A61K49/12, A61P29/00, A61K9/14, A61K9/20, A61K9/22, A61K9/48, A61K9/52, A61K9/66, A61K9/70, A61F2/00 | [2018/03] | CPC: |
A61K49/0054 (EP,US);
A61K47/58 (EP,US);
A61K49/0041 (EP,US);
A61K49/128 (EP,US);
A61P29/00 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2018/03] | Title | German: | MAKROMOLEKULARE ABGABESYSTEME ZUR NICHTINVASIVEN DARSTELLUNG, BEURTEILUNG UND BEHANDLUNG VON ARTHRITIS UND ANDEREN ENTZÜNDLICHEN ERKRANKUNGEN | [2018/03] | English: | MACROMOLECULAR DELIVERY SYSTEMS FOR NON-INVASIVE IMAGING, EVALUATION AND TREATMENT OF ARTHRITIS AND OTHER INFLAMMATORY DISEASES | [2018/03] | French: | SYSTÈMES D'ADMINISTRATION MACROMOLÉCULAIRES DESTINÉS À L'IMAGERIE NON INVASIVE, L'ÉVALUATION ET LE TRAITEMENT DE L'ARTHRITE ET D'AUTRES MALADIES INFLAMMATOIRES | [2018/03] | Examination procedure | 29.08.2017 | Examination requested [2018/03] | 29.08.2017 | Date on which the examining division has become responsible | 26.10.2018 | Amendment by applicant (claims and/or description) | 23.10.2019 | Despatch of a communication from the examining division (Time limit: M06) | 27.03.2020 | Reply to a communication from the examining division | 01.03.2021 | Communication of intention to grant the patent | 13.07.2021 | Application deemed to be withdrawn, date of legal effect [2021/51] | 04.08.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2021/51] | Parent application(s) Tooltip | EP05732710.8 / EP1737428 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 26.10.2018 | Request for further processing filed | 26.10.2018 | Full payment received (date of receipt of payment) Request granted | 08.11.2018 | Decision despatched | The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application | 26.10.2018 | Request for further processing filed | 26.10.2018 | Full payment received (date of receipt of payment) Request granted | 08.11.2018 | Decision despatched | Fees paid | Renewal fee | 29.08.2017 | Renewal fee patent year 03 | 29.08.2017 | Renewal fee patent year 04 | 29.08.2017 | Renewal fee patent year 05 | 29.08.2017 | Renewal fee patent year 06 | 29.08.2017 | Renewal fee patent year 07 | 29.08.2017 | Renewal fee patent year 08 | 29.08.2017 | Renewal fee patent year 09 | 29.08.2017 | Renewal fee patent year 10 | 29.08.2017 | Renewal fee patent year 11 | 29.08.2017 | Renewal fee patent year 12 | 29.08.2017 | Renewal fee patent year 13 | 28.02.2018 | Renewal fee patent year 14 | 19.03.2019 | Renewal fee patent year 15 | 28.02.2020 | Renewal fee patent year 16 | Penalty fee | Additional fee for renewal fee | 31.03.2021 | 17   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XYI]EP0331471 (SELCH LARSEN CLAUS [DK], et al) [X] 1,6,7,9,11,18,19 * page 23, paragraph 4 - page 33, paragraph 2 * * page 2, line 45 * * page 8, line 22 - line 58 * [Y] 13 [I] 5,12,14,15; | [XYI] - KAKIMOTO K ET AL, "The suppressive effect of gelatin-conjugated superoxide dismutase on disease development and severity of collagen-induced arthritis in mice", CLINICAL AND EXPERIMENTAL IMMUNOLOGY, (1993), vol. 94, no. 2, ISSN 0009-9104, pages 241 - 246, XP002609049 [X] 1,6,7,10,18,19 * abstract * * page 242, column 1, paragraph 4 * [Y] 13 [I] 5,12,14,15 | [XAI] - GUPTA H ET AL, "INFLAMMATION: IMAGING WITH METHOXY POLY(ETHYLENE GLYCOL)-POLY-L-LYSINE-DTPA, A LONG-CIRUCLATING GRAFT COPOLYMER", RADIOLOGY, RADIOLOGICAL SOCIETY OF NORTH AMERICA, OAK BROOK,IL, US, (19951201), vol. 197, no. 3, ISSN 0033-8419, pages 665 - 669, XP002037429 [X] 2,4,7,8,21-23 * abstract * * figures 1-4 * * page 669, column 1, paragraph 2 * * page 665, column 3, paragraph 2 * [A] 20,24 [I] 3,5,9,10,14,15,18 | [XD] - TIMOFEEVSKI S L ET AL, "Anti-inflammatory and antishock water-soluble polyesters of glucocorticoids with low level systemic toxicity", PHARMACEUTICAL RESEARCH 1996 US LNKD- DOI:10.1023/A:1016069315423, (1996), vol. 13, no. 3, ISSN 0724-8741, pages 476 - 480, XP002609050 [XD] 1,9,11,17,18 * abstract * * page 477, column 2, paragraph 4 * DOI: http://dx.doi.org/10.1023/A:1016069315423 | [X] - WANG L F ET AL, "pH sensitive polymeric prodrugs containing ibuprofen, ketoprofen and naproxen as pendent groups", JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, SAGE, US, (19990101), vol. 14, no. 5, ISSN 0883-9115, pages 415 - 428, XP002184407 [X] 1,9,17,18 * abstract * * scheme 1 * * page 424, line 3 - line 10 * | [XDAY] - WANG D ET AL, "Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems", BIOCONJUGATE CHEMISTRY 200309 US LNKD- DOI:10.1021/BC034090J, (200309), vol. 14, no. 5, ISSN 1043-1802, pages 853 - 859, XP002609051 [XD] 2,3,5,7,8,10,12,13,15-17,21 * abstract * * scheme 2 and 3 * * page 858, column 1, paragraph 3 * [A] 20,22-24 [Y] 13 DOI: http://dx.doi.org/10.1021/bc034090j | by applicant | US4034040 | - BERGE et al., "Pharmaceutical Salts", J. of Pharma Sci., (19770000), vol. 66, doi:doi:10.1002/jps.2600660104, pages 1 - 19, XP002675560 DOI: http://dx.doi.org/10.1002/jps.2600660104 | - G.S. FIRESTEIN, "Etiology and Pathogenesis of Rheumatoid Arthritis", G.S. FIRESTEIN, S. Ruddy, E. D. Harris Jr. and C. B. Sledge, Kelley's Textbook of Rheumatology, 6th ed., W.B. Saunders Company, (19970000), page 921 | - F. C. MCDUFFIE, "Morbidity impact of rheumatoid arthritis in society", Am. J. Med., (19850000), vol. 78, doi:doi:10.1016/0002-9343(85)90237-2, pages 1 - 5, XP023308083 DOI: http://dx.doi.org/10.1016/0002-9343(85)90237-2 | - J. S. SMOLEN; G. STEINER, "Therapeutic strategies for rheumatoid arthritis", Nature Review Drug Discovery, (20030000), vol. 2, pages 473 - 488 | - W. J. WALLIS; P. A. SIMKIN; W. B. NELP, "Protein traffic in human synovial effusion", Arthritis and Rheumatism, (19870000), vol. 30, pages 57 - 63 | - J. R. LEVICK, "Permeability of rheumatoid and normal human synovium to specific plasma proteins", Arthritis and Rheumatism, (19810000), vol. 24, pages 1550 - 1560 | - M. ALBUQUERQUE; J. P. DE LIMA, "Articular lymphoscintigraphy in human knees using radiolabeled dextran", Lymphology, (19900000), vol. 23, pages 215 - 218 | - L. S. WILKINSON; J. C. W., "Edwards. Demonstration of lymphatics in human synovial tissue", Rheumatol. Int., (19910000), vol. 11, pages 151 - 155 | - E. L. MATTESON, "Current treatment strategies for rheumatoid arthritis", Mayo Clin. Proc., (20000000), vol. 75, doi:doi:10.4065/75.1.69, pages 69 - 74, XP000944521 DOI: http://dx.doi.org/10.4065/75.1.69 | - E. SANTANA-SAHAGUN; M. H. WEISMAN, "Nonsteroidal Anti-inflammatory Drugs", E. SANTANA-SAHAGUN; M. H. WEISMAN, S. Ruddy, E. D. Harris Jr. and C. B. Sledge, Kelley's Textbook of Rheumatology, W.B. Saunders Company, (19970000), pages 799 - 822 | - C. M. STEIN; T. PINCUS, "Glucocorticoids", C. M. STEIN; T. PINCUS, S. Ruddy, E. D. Harris Jr. and C. B. Sledge, Kelley's Textbook of Rheumatology, 6th ed., W.B. Saunders Company, (19970000), pages 823 - 840 | - J. KOPECEK; P. KOPECKOVA; T. MINKO; Z. R. LU, "HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action", Eur. J. Pharm. Biopharm., (20000000), vol. 50, doi:doi:10.1016/S0939-6411(00)00075-8, pages 61 - 81, XP004257180 DOI: http://dx.doi.org/10.1016/S0939-6411(00)00075-8 | - L. W. SEYMOUR, "Passive tumor targeting of soluble macromoleculaes and drug conjugates", Critical Reviews In Therapeutic Drug Carrier Systems, (19920000), vol. 9, pages 135 - 187 | - J. M. METSELAAR; M. H. WAUBEN; J. P. WAGENAAR-HILBERS; O. C. BOERMAN; G. STORM, "Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes", Arthritis Rheum, (20030000), vol. 48, doi:doi:10.1002/art.11140, pages 2059 - 2066, XP002609052 DOI: http://dx.doi.org/10.1002/art.11140 | - M. N. J. PALEY; I. D. WILKINSON; E. VAN BEEK; P. D. GRIFFITHS, "Magnetic resonance imaging: basic principles", M. N. J. PALEY; I. D. WILKINSON; E. VAN BEEK; P. D. GRIFFITHS, R. G. Grainger, D. Allison, A. Adam and A. K. Dixon, Grainger & Allison's Diagnostic Radiology: A Textbook of Medical Imaging, 4th ed., Churchill Livingstone, Inc, (20010000), pages 101 - 136 | - J. KOPECEK; H. BAZILOVA, "Poly[N-(2-hydroxypropyl) methacrylamide]. I. Radical polymerization and copolymerization", Eur. Polym. J., (19730000), vol. 9, doi:doi:10.1016/0014-3057(73)90063-3, pages 7 - 14, XP025863514 DOI: http://dx.doi.org/10.1016/0014-3057(73)90063-3 | - V. OMELYANENKO; P. KOPECKOVA; C. GENTRY; J. KOPECEK, "Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate", J. Controlled Release, (19980000), vol. 53, doi:doi:10.1016/S0168-3659(97)00235-6, pages 25 - 37, XP004121254 DOI: http://dx.doi.org/10.1016/S0168-3659(97)00235-6 | - S. MOORE; W. H. STEIN, "A modified ninhydrin reagent for the photometric determination of amino acids and related compounds", J. Biol. Chem., (19540000), vol. 211, pages 907 - 913 | - Z. R. LU; X. WANG; D. L. PARKER; K. C. GOODRICH; H. R. BUSWELL, "Poly(l-glutamic acid) Gd(III)-DOTA conjugate with a degradable spacer for magnetic resonance imaging", Bioconjug Chem., (20030000), vol. 14, doi:doi:10.1021/bc0340464, pages 715 - 719, XP002490707 DOI: http://dx.doi.org/10.1021/bc0340464 | - A. M. BENDELE, "Animal models of rheumatoid arthritis", J. Musculoskel. Neuron. Interact., (20010000), vol. 1, pages 377 - 385 | - D. WANG; S. C. MILLER; M. SIMA; P. KOPECKOVA; J. KOPECEK, "Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems", Bioconjug. Chem., (20030000), vol. 14, doi:doi:10.1021/bc034090j, pages 853 - 859, XP002609051 DOI: http://dx.doi.org/10.1021/bc034090j | - I. KUSHNER; J. A. SOMERVILLE, "Permeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammation", Arthritis and Rheumatism, (19710000), vol. 14, pages 560 - 570 | - T. P. JACOBS; O. KEMPSKI; D. MCKINLEY; A. J. DUTKA; J. M. HALLENBECK; G. FEUERSTEIN, "Blood flow and vascular permeability during motor dysfunction in a rabbit model of spinal cord ischemia", Stroke, (19920000), vol. 23, pages 367 - 373 | - Y. MATSUMURA; H. MAEDA, "A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs", Cancer Res., (19860000), vol. 46, pages 6387 - 6392, XP002084436 | - "Principles of Magnetic Resonance Imaging", M. A. BROWN; R. C. SEMELKA, MRI: Basic Principles and Applications, 3rd ed., Wiley-Liss, (20030000), pages 27 - 42 | - D. CLAVEAU; M. SIRINYAN; J. GUAY; R. GORDON; C. C. CHAN; Y. BUREAU; D. RIENDEAU; J. A. MANCINI, "Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model", J. Immunol., (20030000), vol. 170, pages 4738 - 4744, XP002356597 | - M. I. V. JAYSON; A. ST. J. DIXON, "Intra-articular pressure in the rheumatoid arthritis of knee. I. Pressure changes during passive joint distension", Ann. Rheum. Dis., (19700000), vol. 29, pages 261 - 265 | - Y. OKADA, "Proteinases and Matrix Degradation", Y. OKADA, S. Ruddy, E. D. Harris Jr. and C. B. Sledge, Kelley's Textbook of Rheumatology, 6th ed., Saunders Company, (19970000), pages 55 - 72 | - P. S. TREUHAFT; D. J. MCCARTY, "Synovial fluid pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases", Arthritis and Rheumatism, (19710000), vol. 14, pages 475 - 484 | - I. GIRAUD; M. RAPP; J. C. MAURIZIS; J. C. MADELMONT, "Application to a cartilage targeting strategy: synthesis and in vivo biodistribution of 14 C-labeled quaternary ammonium-glucosamine conjugates", Bioconjug. Chem., (20000000), vol. 11, doi:doi:10.1021/BC990128+, pages 212 - 218, XP002611626 DOI: http://dx.doi.org/10.1021/BC990128+ | - M. RAPP; GIRAUD I.; MAURIZIS J.C.; GALMIER M.J.; MADELMONT J.C., "Synthesis and in vivo biodisposition of [14C]-quaternary ammonium-melphalan conjugate, a potential cartilage-targeted alkylating drug", Bioconjug Chem., (20030000), vol. 14, no. 2, doi:doi:10.1021/bc020031e, pages 500 - 6, XP055030105 DOI: http://dx.doi.org/10.1021/bc020031e | - A. WUNDER; MULLER-LADNER U.; STELZER E.H.; FUNK J.; NEUMANN E.; STEHLE G.; PAP T.; SINN H.; GAY S.; FIEHN C, "Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis", J. Immunol., (20030000), vol. 170, no. 9, pages 4793 - 801, XP002371816 | - S. L. TIMOFEEVSKI; PANARIN E.F.; VINOGRADOV O.L.; NEZHENTSEV M.V., "Anti-inflammatory and antishock water-soluble polyesters of glucocorticoids with low level systemic toxicity", Pharm Res., (19960000), vol. 13, no. 3, doi:doi:10.1023/A:1016069315423, pages 476 - 80, XP002609050 DOI: http://dx.doi.org/10.1023/A:1016069315423 | - H. KITAMURA; KATO A.; ESAKI T, "AG-041R, a novel indoline-2-one derivative, induces systemic cartilage hyperplasia in rats", Eur J. Pharmacol., (20010000), vol. 418, no. 3, pages 225 - 30 | - F. DEMSAR; VAN DIJKE C.F.; KIRK B.A.; KAPILA S.; PETERFY C.G.; ROBERTS T.P.; SHAMES D.M.; TOMAZIC S.; MANN J.; BRASCH R.C., "Mapping abnormal synovial vascular permeability in temporomandibular joint arthritis in the rabbit using MRI", Br. J. Rheumatol., (19960000), vol. 35, no. 3, pages 23 - 25 | - P. B. JACOBSON; MORGAN S.J.; WILCOX D.M.; NGUYEN P.; RATAJCZAK C.A.; CARLSON R.P.; HARRIS R.R., "Nuss M. A new spin on an old model: in vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parameters and histopathology in the adjuvant arthritic rat", Arthritis Rheum., (19990000), vol. 42, no. 10, pages 2060 - 73 |